ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients’ device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; and connectivity module and propeller solutions. In addition, it offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice agencies, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. T
ResMed Inc.
Unlock to Claim this listing
Add / Modify Company
3.8
Overall Excellence Rating
Industry
HealthcareCategory
Medical Instruments & SuppliesESG/Ethical Impact
Between 2017 and 2019, there has been a noticeable increase in inquiries from customers on the source, content, and environmental performance of our products.This is in addition to the increasing appearance of sustainability credentials in requests for tenders, particularly from the hospital sector. Each inquiry raises internal consideration of our existing manufacturing and supply chain processes, and the extent to which we weigh environmental factors against operational and financial factors in our decision making. We insist on and achieve strong compliance with environmental regulations, with no material breaches, and have seen improvements in material efficiency and recycling in both production and administrative areas. We are extending our adoption of ISO 14001 standards, which reflect the need to conserve scarce resources and protect our natural ecologies. We have invested in environmental stewardship at our sites, and are committed to extending that stewardship to our product design and packaging. At this stage, we are comfortable that our quality management system, with our pursuit of lean manufacturing and continuous improvement, is delivering environmental improvements in a way that is both effective and integrated with our core business.Our community contributions reflect our mission to improve millions of lives worldwide through the treatment of chronic diseases like sleep apnea, COPD, and asthma, plus improved management of consumers benefiting from out-of-hospital care. We target research in those areas and also help our employees support their communities in the form of volunteer hours and matching charity donations where appropriate. We further respect our communities by being vigilant in meeting our product quality, safety, and marketing obligations, as well as with customer data privacy. Our core business is improving people’s health and wellbeing by treating their sleep apnea, COPD, asthma, or other chronic conditions. Accordingly, most of our community engagement is on health- related matters, and we continue to raise awareness through market and clinical initiatives of the increasing link between the potential effects sleep apnea, COPD, asthma, and other respiratory conditions can have on one another as well as on other chronic conditions such as cardiovascular diseases, stroke, high blood pressure, obesity, and diabetes.Our corporate governance principles outline how we hold ourselves accountable to shareholders and stakeholders.These principles address the operation of our board and its sub-committees; strategic and succession planning; and director qualifications. Our board has adopted corporate governance guidelines to assist in exercising its responsibilities in accordance with our constitution and all applicable laws and regulations. These include the regulations of the US Securities and Exchange Commission (SEC) and the rules of both the New York Stock Exchange (NYSE) and the Australian Securities Exchange (ASX), on which ResMed is listed. Our board will continue to evaluate its governance structures as ResMed’s business evolves to ensure that we manage the business for the long-term interests of our shareholders and other stakeholders. A more detailed review of our governance is provided in our annual proxy statement to shareholders, issued under section 14(a) of the Securities Exchange Act.ResMed provides solutions for sleep disorders and respiratory conditions. Its focus on respiratory health contributes to its financial stability. ResMed generates revenue from the sale of devices and equipment for sleep apnea and other respiratory disorders.ResMed’s overall strategy is grounded in our business sustainability because innovation, ethical business practices, and operational excellence are precisely what enable us to save and enrich millions of lives. In short, our approach to the environment, our social communities, and best-practice governance is simply part of our DNA. We believe that the altruistic goal of helping people sleep better, breathe better, and live higher-quality lives away from a hospital in an ethical, compliant, and sustainable manner is quite simply key to our company’s growth so that we can serve hundreds of millions of people who need our help.
Eligible Awards
Coming Soon
Claim Your Award Badges
Do you work with Us
Awards Received
2023
Revenues
$3,500,000,000.00
Website Traffic
Employee Rating
4.1
Customer Rating
3.8
Company Size
5000-10000
ESG Risk Rating
3